ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
Polo-Like Kinase 1 Phosphorylation Tunes the Functional Viscoelastic Properties of the Centrosome Scaffold.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Polo-Like Kinase 1 Phosphorylation Tunes the Functional Viscoelastic Properties of the Centrosome Scaffold.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
Corrections and comments
- Update of
Authors and funding
6 authors.
Funding
Abstract
Cytoskeleton-organizing organelles often function while under mechanical load. The outer layer of centrosomes, called pericentriolar material (PCM), nucleates microtubules that move chromosomes during mitosis. How PCM resists microtubule-mediated forces is poorly understood at the material level. This study shows that PLK-1 phosphorylation of SPD-5 tunes the dynamics and material properties of the PCM scaffold in C. elegans embryos. Microrheology of reconstituted SPD-5 scaffolds reveals that PLK-1 phosphorylation decreases SPD-5 dynamics and increases scaffold viscoelasticity. Similarly, in embryos, phospho-mimetic SPD-5 is less dynamic than wild-type SPD-5, which itself is less dynamic than phospho-null SPD-5. PCM built with phospho-null SPD-5 is smaller than normal, but its assembly can be partially rescued by reducing microtubule-dependent forces. The same is true for PCM built with phospho-mimetic SPD-5, yet the underlying causes are distinct: under force, phospho-null SPD-5 fails to assemble, while phospho-mimetic SPD-5 forms hyper-stable foci that fail to cohere into a uniform, spherical mass. Both mutants have defects with chromosome segregation and viability. Thus, tuning of SPD-5 phosphorylation optimizes PCM material properties to achieve correct PCM size, integrity, and function. These results demonstrate how regulated chemical modification of a scaffolding protein tunes the material properties and function of a microtubule-organizing organelle.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.